Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis

Keyphrases

• Nasal Polyposis 100%
• Immunopathogenesis 100%
• Chronic Rhinosinusitis 100%
• Pathogenic Mechanism 28%
• Mast Cells 28%
• Quality of Life 14%
• Th2 Cytokines 14%
• Homeostasis 14%
• Interleukin-13 (IL-13) 14%
• Antimicrobial 14%
• Normal Function 14%
• Surgical Intervention 14%
• Inflammatory Cells 14%
• Eosinophils 14%
• Chronic Inflammatory Diseases 14%
• Adult Population 14%
• Nasal Polyps 14%
• Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) 14%
• Lymphoid Tissue 14%
• Group 2 Innate Lymphoid Cells 14%
• Treatment Paradigms 14%
• Years of Life Lost 14%
• One-form 14%
• Enhanced Permeability 14%
• Biological Drugs 14%
• Basophils 14%
• Th2 Cells 14%
• Immune Barrier 14%
• Interleukin-5 (IL-5) 14%
• Paranasal Sinuses 14%
• Lost Time 14%
• Geographical Location 14%
• Mucosal Epithelium 14%
• Antimicrobial Response 14%
• Main Forms 14%
• Lost Productive Time 14%
• Geographical Races 14%

Immunology and Microbiology

• Immunopathogenesis 100%
• Cytokine 100%
• Mast Cell 66%
• Basophil Granulocyte 33%
• Eosinophil Granulocyte 33%
• Innate Lymphoid Cell 33%
• Lymphoid Tissue 33%
• Inflammatory Disorder 33%
• Nose 33%
• Inflammatory Cell 33%
• Homeostasis 33%
• Immunity 33%
• Interleukin 13 33%
• Th2 Cell 33%
• Paranasal Sinus 33%
• Interleukin 5 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Nose Polyp 100%
• Chronic Rhinosinusitis 100%
• Immunopathogenesis 100%
• Cytokine 37%
• Inflammatory Disease 12%
• Antiinfective Agent 12%
• Polyp 12%
• Interleukin 13 12%
• Interleukin 5 12%